SCHEMBL17355688

SCHEMBL17355688

Cc1cc(C)c(S(=O)(=O)Oc2ccc(F)c(C)c2)c(C)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.54
MEN1 O00255 4/20 0.54
LMNA P02545 3/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
MAPT P10636 1/20 0.54
RAPGEF4 Q8WZA2 5/20 0.44
ALDH1A1 P00352 1/20 0.41
KEAP1 Q14145 2/20 0.39
NFE2L2 Q16236 2/20 0.39
POLB P06746 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
MMP1 P03956 1/20 0.36
MMP2 P08253 1/20 0.36
MMP9 P14780 1/20 0.36
MMP8 P22894 1/20 0.36
MMP13 P45452 1/20 0.36
FFAR4 Q5NUL3 2/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17355696 0.85 CA1 (0.46) KMT2AMEN1LMNASMN1; SMN2MAPT
SCHEMBL17356432 0.85 MAPT (0.49) KMT2AMEN1LMNASMN1; SMN2MAPT
SCHEMBL6241668 0.81 LMNA (0.65) KMT2AMEN1LMNASMN1; SMN2MAPT
SCHEMBL17355689 0.81 KMT2A (0.55) KMT2AMEN1LMNASMN1; SMN2MAPT
SCHEMBL9957940 0.78 RAPGEF4 (0.65) KMT2AMEN1LMNASMN1; SMN2MAPT
SCHEMBL7247499 0.78 ALDH1A1 (0.49) KMT2ASMN1; SMN2ALDH1A1CA2TSHR
SCHEMBL17355677 0.78 PTGS2 (0.39) KMT2ASMN1; SMN2POLBCA1CA2
SCHEMBL17355694 0.77 KMT2A (0.46) KMT2AMEN1LMNASMN1; SMN2TSHR
SCHEMBL17355680 0.77 TDP1 (0.56) KMT2AMEN1LMNASMN1; SMN2MAPT
SCHEMBL17355692 0.77 AKR1C3 (0.47) KMT2AMEN1LMNASMN1; SMN2CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150372349-A1 NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE UBE INDUSTRIES, LTD. (JP) 2015-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150372349-A1 NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE HCN2, SCO2, HCN1 KMT2A 2355/4885MEN1 4646/4885LMNA 1291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.